Understanding the Seed Storage Protein Ara h 6 in Predicting Severe Peanut Reactions
Peanut allergy is one of the most widely discussed food allergies in the UK, and for good reason — reactions can range from mild oral discomfort to life-threatening anaphylaxis. Within the field of molecular allergy testing, understanding specific peanut allergen components has become increasingly important. One component in particular — Ara h 6 — is emerging as a clinically significant marker in predicting severe peanut reactions. This educational guide explores what Ara h 6 is, why it matters, and how allergy component blood testing can provide meaningful insight for those managing peanut sensitivity.
What Is Ara h 6? A Snapshot Definition
Ara h 6 is a seed storage protein found in peanuts, belonging to the 2S albumin protein family. It is considered a major peanut allergen due to its heat and digestion stability, meaning it retains its allergenic structure even after cooking or digestion. Research suggests that IgE sensitisation to Ara h 6 may be associated with a higher likelihood of systemic, potentially severe allergic reactions compared to sensitisation to some other peanut components.
In brief: Ara h 6 is a stable peanut seed protein that resists breakdown during digestion, and elevated IgE levels to this component may indicate a greater risk of clinically significant allergic reactions.
Why Seed Storage Proteins Matter in Allergy Risk Assessment
Not all peanut proteins are created equal. The allergenic potential of individual peanut components varies considerably. Seed storage proteins — including Ara h 1, Ara h 2, Ara h 3, and Ara h 6 — are structurally robust proteins that tend to survive food processing and digestion. This stability is central to their potential to trigger immune responses.
Key peanut seed storage proteins include:
- Ara h 1 – Vicilin-type storage protein; frequently linked to severe reactions
- Ara h 2 – 2S albumin; considered a primary marker for systemic reactions
- Ara h 3 – Legumin-type protein; associated with significant allergic responses
- Ara h 6 – 2S albumin; increasingly recognised alongside Ara h 2 as a key predictor of severe reactions
- Ara h 8 – PR-10 protein; more often associated with oral allergy syndrome and milder symptoms
Practical Insight: Because Ara h 6 and Ara h 2 share structural similarities as 2S albumins, some evidence suggests they may work synergistically — meaning a person sensitised to both components may carry a higher cumulative risk profile than someone sensitised to only one.
How Ara h 6 Compares to Other Key Peanut Components
| Peanut Component | Protein Family | Heat/Digestion Stability | Typical Reaction Profile |
|---|---|---|---|
| Ara h 1 | Vicilin (7S) | Moderate | Systemic reactions possible |
| Ara h 2 | 2S Albumin | High | Strong predictor of severe reactions |
| Ara h 3 | Legumin (11S) | High | Associated with systemic reactions |
| Ara h 6 | 2S Albumin | High | Emerging predictor of severe reactions |
| Ara h 8 | PR-10 | Low | Mild/oral allergy syndrome |
| Ara h 9 | Lipid Transfer Protein | Moderate–High | Variable; geographic influence |
This comparison highlights that Ara h 6, alongside Ara h 2, sits in the higher-risk category of peanut allergen components based on protein stability and associated IgE response patterns.
Component Resolved Diagnostics (CRD): Moving Beyond Total IgE Testing
Traditional allergy blood tests measure total IgE or whole-peanut-extract IgE. Whilst informative, these tests do not distinguish between which individual proteins within the peanut are driving the immune response. Component Resolved Diagnostics (CRD) — sometimes called molecular allergy testing — takes a more refined approach.
By measuring IgE antibodies to specific individual allergen molecules such as Ara h 2, Ara h 3, or Ara h 6, CRD testing can provide a more detailed picture of the sensitisation profile. This level of detail may help distinguish between:
- True systemic sensitisation — linked to stable proteins such as Ara h 6 and Ara h 2
- Cross-reactive sensitisation — often linked to less stable proteins like Ara h 8, which may produce milder, pollen-related symptoms
Practical Insight: Component testing does not diagnose allergy — that remains the role of an appropriate clinical assessment. However, a detailed IgE component profile can provide valuable information that supports informed conversations with healthcare professionals.
Who Should Consider Peanut Component Allergy Blood Testing?
Peanut component testing, including Ara h 6, may be of interest to a range of individuals. It is important to note that testing is a screening and informational service — it does not replace clinical assessment or medical advice.
You may wish to explore component allergy blood testing if you:
- Have a known or suspected peanut sensitivity and want a more detailed understanding of your IgE profile
- Have previously tested positive for whole-peanut IgE but want insight into which specific components may be relevant
- Experience unexplained or recurring allergic-type reactions following peanut or tree nut exposure
- Have a family history of peanut allergy and are seeking baseline information
- Are monitoring a child's allergy component profile over time (with appropriate healthcare involvement)
- Want a thorough allergy screen as part of proactive health management
For further background on how food allergy IgE testing works, you may find our resource on food allergy blood testing a useful starting point.
What Your Ara h 6 Results May Suggest
Results from a peanut component allergy test are reported as IgE antibody levels, measured in kUA/L (kilounits of allergen per litre). Whilst interpretation should always be undertaken alongside a qualified healthcare professional, the following general framework is commonly used in the UK:
| IgE Level (kUA/L) | Class | General Interpretation |
|---|---|---|
| < 0.35 | 0 | Below detection threshold |
| 0.35 – 0.70 | 1 | Low level — may suggest mild sensitisation |
| 0.70 – 3.50 | 2 | Moderate sensitisation possible |
| 3.50 – 17.50 | 3 | Elevated — may suggest significant sensitisation |
| > 17.50 | 4–6 | High — warrants prompt professional review |
Elevated Ara h 6 IgE levels — particularly when combined with raised Ara h 2 — may suggest a sensitisation pattern associated with a higher risk of clinically significant reactions. However, IgE levels alone do not confirm clinical allergy, and results should be considered in the broader clinical context.
Practical Insight: A result does not tell you definitively how you will react. It can suggest the potential for reaction and the nature of sensitisation — information that can be genuinely useful when shared with an appropriate healthcare professional.
If you are interested in exploring a wider allergy profile, you may find it helpful to browse our allergy testing page for an overview of the panels we offer.
How Often Should Allergy Component Testing Be Considered?
The frequency of allergy blood testing depends on individual circumstances. As a general educational guide:
- Initial baseline testing may be appropriate if you have suspected but unconfirmed peanut sensitivity
- Annual or biennial monitoring is sometimes considered in individuals with a known sensitisation, to track IgE trends over time
- Post-reaction retesting may be informative following a significant allergic event
- Childhood monitoring — peanut allergy profiles can shift during childhood, and periodic testing may provide useful longitudinal data
Any decisions around testing frequency should be made in conjunction with appropriate healthcare guidance.
London and UK Context: Accessing Allergy Component Testing Privately
In London and across the UK, access to detailed molecular allergy testing through the NHS can be variable, often dependent on referral pathways and local commissioning priorities. Private allergy clinics and nurse-led screening services offer an accessible route to component-level IgE blood testing, without requiring a GP referral.
For Londoners seeking a thorough allergy blood screen, private testing services can provide timely results with detailed component breakdowns — enabling individuals to have better-informed conversations with their healthcare team. You can learn more about our approach by visiting the Allergy Clinic London homepage.
NHS vs Private Allergy Testing — A Neutral Comparison:
| Feature | NHS Pathway | Private Testing Clinic |
|---|---|---|
| Referral required | Usually yes | No |
| Waiting times | Variable | Typically shorter |
| Component-level testing availability | Dependent on referral | More readily accessible |
| Results turnaround | Varies by Trust | Often faster |
| Cost | Free at point of care | Fee-based |
Frequently Asked Questions About Ara h 6 and Peanut Component Testing
1. What is Ara h 6 and why is it important in peanut allergy?
Ara h 6 is a seed storage protein (2S albumin) found in peanuts. It is considered clinically significant because it is highly stable — resistant to heat and digestion — and IgE sensitisation to Ara h 6 may indicate an elevated risk of systemic peanut reactions compared to sensitisation to more unstable components.
2. Is Ara h 6 the same as Ara h 2?
No, though they are closely related. Both Ara h 2 and Ara h 6 belong to the 2S albumin family and share structural similarities. They are often elevated together in individuals with significant peanut sensitisation. Research suggests that combined Ara h 2 and Ara h 6 sensitisation may carry a higher predictive value than either alone.
3. Can a positive Ara h 6 IgE result confirm that I am allergic to peanuts?
No. A positive IgE result indicates sensitisation — that your immune system has produced antibodies to the Ara h 6 protein. Sensitisation does not automatically mean clinical allergy. Results should always be interpreted alongside symptoms and appropriate professional assessment.
4. Where can I get peanut component allergy blood testing in London?
Peanut component testing including Ara h 6 and Ara h 2 is available through private allergy testing clinics in London, including nurse-led services. You can explore testing options at allergyclinic.co.uk.
5. What is Component Resolved Diagnostics (CRD)?
Component Resolved Diagnostics (CRD) is a form of molecular allergy blood testing that measures IgE antibodies to specific individual allergen molecules rather than whole-food extracts. It provides a more detailed sensitisation profile, helping to differentiate between clinically significant and cross-reactive sensitisation patterns.
6. Is Ara h 6 testing included in a standard allergy blood test?
Standard allergy panels often test whole peanut extract IgE. Ara h 6 component testing is typically part of a more detailed molecular allergy panel. Specific test inclusions vary — it is worth checking with the testing provider which components are included.
7. Can children be tested for Ara h 6 sensitisation?
Yes, blood-based allergy component tests can be carried out in children. The suitability of testing and interpretation of results in paediatric cases should be discussed with an appropriate healthcare professional, as peanut allergy profiles can evolve during childhood.
8. Does a low Ara h 6 IgE result mean I can safely eat peanuts?
Not necessarily. A low result may suggest lower sensitisation to this specific component, but it does not rule out allergic reactions. Allergy risk involves multiple components and individual factors. Please seek guidance from an appropriate healthcare professional before making any dietary changes if you have a known or suspected peanut allergy.
9. What is the difference between Ara h 6 and Ara h 8 in terms of reaction risk?
Ara h 6 is a stable seed storage protein associated with higher systemic reaction risk. Ara h 8 is a PR-10 protein that is structurally less stable and commonly cross-reacts with birch pollen — typically associated with milder oral allergy syndrome symptoms. The distinction between these components is clinically meaningful.
10. Can I book a peanut component allergy test without a GP referral?
Yes. Private nurse-led allergy testing services in the UK typically do not require a GP referral. You can self-refer for a component allergy blood test and receive detailed results, which you may then share with your healthcare team.
A Note on Our Service
The Allergy Clinic at allergyclinic.co.uk is a nurse-led health screening service based in London. We provide allergy blood testing and reporting only. We do not offer GP services, prescriptions, specialist treatments, or diagnostic procedures beyond blood testing. Our results reports are designed to support informed discussions with your own healthcare team.
For those seeking greater clarity around their allergy profile, we offer a range of evidence-informed blood testing options. To explore what may be appropriate for your circumstances, visit our allergy testing information page.
Conclusion: The Clinical Value of Ara h 6 in Peanut Allergy Assessment
As our understanding of molecular allergy testing continues to advance, the role of individual peanut components such as Ara h 6 has become increasingly recognised. By offering a more precise picture of IgE sensitisation profiles, component testing moves beyond the blunt instrument of whole-extract IgE and provides nuanced, clinically relevant information.
For individuals in the UK who are managing peanut sensitivity — or seeking to understand their allergy risk more thoroughly — exploring Ara h 6 component testing alongside broader panels may be a meaningful step. Knowledge of your sensitisation profile, shared with an appropriate healthcare professional, can form a valuable part of a proactive approach to your health.
Proactive awareness, rather than anxiety, is always the aim. If you would like to understand your allergy profile more clearly, consider speaking to a qualified healthcare professional or exploring the testing options available through our clinic.
Disclaimer
This article has been written for educational and informational purposes only. The content does not constitute medical advice, diagnosis, or treatment. It is not intended to replace consultation with a qualified healthcare professional. Individual symptoms, concerns, or blood test results should always be assessed by an appropriate healthcare professional. The Allergy Clinic is a nurse-led testing and screening service only — we do not provide medical treatment, prescriptions, specialist consultations, or diagnostic services beyond blood testing. Results from allergy component tests should be interpreted in conjunction with clinical history and professional guidance. No guaranteed outcomes are implied or stated within this content. This article complies with GMC advertising guidance, CQC patient communication standards, and ASA editorial guidelines.
